News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Positive topline results from the Phase 3 PAPILLON study in patients with non-small cell lung cancer – Kiran Patel
Photo taken from: Kiran Patel / LinkedIn
Jul 18, 2023, 05:37

Positive topline results from the Phase 3 PAPILLON study in patients with non-small cell lung cancer – Kiran Patel

Today, The Janssen Pharmaceutical Companies of Johnson & Johnson announced positive topline results from the Phase 3 PAPILLON study in patients with non-small cell lung cancer (NSCLC) characterized by specific genetic alterations.

We’re advancing the science of lung cancer through the development of targeted therapies for patients with genetically-defined NSCLC who often experience poor prognoses and shorter survival.

We remain focused on bringing forward transformative treatment options to reduce the impact of the world’s leading cause of cancer mortality.

Read more about these results: https://bit.ly/3JXLh5l

 

Source: Kiran Patel / LinkedIn

lungcancer NSCLC OncoDaily Oncology Research
Special Coverage
Science
Dec 22, 2024, 04:40
The prevalence of widespread guideline-discordant LDCT screening in a low-risk population by So Yeon Kim et al.
Blog
Dec 22, 2024, 04:38
The new Institute of Cancer Research spinout company Sentinal4D has been announced to the public
Blog
Dec 22, 2024, 04:34
Nermean Mostafa: Honored to co-organize women cancer patient advocacy session hosted by 8th Gyne-Oncology conference
Blog
Dec 22, 2024, 04:24
Jordan Rathkopf: As 2024 winds down, we’ve been reflecting on what a year it’s been
Insight
Dec 22, 2024, 00:21
Eric J. Small: ASCO/Conquer Cancer Foundation Felix Feng Prostate Cancer YIA is now fully endowed
Blog
Dec 21, 2024, 22:40
50 Years of History, a Future to Write Together - AIEOP
Science
Dec 21, 2024, 22:37
Breaking Down the Impact of Ionizing Radiation on Cancer
Blog
Dec 21, 2024, 22:35
Santiago Viteri: Latest findings from the BR.31 trial presented at the 2024 ESMO Congress
Blog
Dec 21, 2024, 22:33
ABIM will develop two new assessment options focusing on breast cancer and hematologic neoplasms
Blog
Dec 21, 2024, 22:28
Adekemi Oyewusi: EDUCARE - Supporting the medical treatment and education of those impacted by childhood cancer
Blog
Dec 21, 2024, 22:26
Anas Younes: Transforming outcomes for people living with Blood Cancer
Blog
Dec 21, 2024, 19:42
Ruben Mesa: Over 200 research staff of Atrium Health Wake Forest Baptist trained on Just Ask Increasing Diversity in Cancer Clinical Trials